Subcutaneous immunoglobulin

DRUG3 trials

Sponsors

University of Aarhus, University Health Network, Toronto

Conditions

HypogammaglobulinemiaMultifocal Motor NeuropathyPolyradiculoneuropathy, Chronic Inflammatory Demyelinating

Phase 2

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

CompletedNCT00268788

University of AarhusMultifocal Motor Neuropathy

Start: 2005-08-31End: 2008-02-29Updated: 2008-02-21

Subcutaneous Immunoglobulin Treatment of Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

CompletedNCT01017159

University of AarhusPolyradiculoneuropathy, Chronic Inflammatory Demyelinating

Start: 2010-04-30End: 2011-11-30Updated: 2011-11-10

Unknown Phase

Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients

CompletedNCT03401268

University Health Network, TorontoHypogammaglobulinemia

Start: 2018-02-01End: 2019-05-01Updated: 2019-05-09

Related Papers

Subcutaneous immunoglobulin in allogeneic hematopoietic cell transplant patients

Hematology/Oncology and Stem Cell Therapy2021-02-236 citations